| Home Forums |
|
|||||||
| Drugs and Drug Treatments ATG, Cyclosporine, Revlimid, Vidaza, Dacogen, ... |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Tue Jun 22, 2010, 06:52 PM
|
|||
|
|||
|
Mylotarg pulled from market
This drug was used for re-occurring AML but is being pulled from the market the drug manufacturer.
http://www.drugwatch.com/news/2010/0...fety-concerns/
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K. 
|
|
#2
Tue Jun 22, 2010, 09:32 PM
|
|||
|
|||
|
It's too bad, since it was for AML patients who couldn't use other chemotherapy treatments.
Mylotarg was approved under one of the FDA's rapid approval programs, but it was later found to increase mortality by 4 times.
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| AML and Mylotarg | Linda E. | Questions and Answers | 2 | Thu Apr 12, 2007 07:28 AM |
